Intracerebroventricular (icv) infusions of relaxin-3 and selective RXFP3 agonists in rat activate PVN CRF neurons and the HPA axis [32], and modulate anxiety and depressive-like behaviour, respectively [33]. The gene discussed is RLN3; the disease is Anxiety.